3 days Ago By ABMN Staff
Zions Bancorporation N.A. decreased its holdings in Centene Co.
( NYSE:CNC – Free Report ) by 21.5% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,027 shares of the company’s stock after selling 555 shares during the quarter.
Zions Bancorporation N.A.’s holdings in Centene were worth $134,000 as of its most recent filing with the SEC.
Other large investors also recently modified their holdings of the company. Rise Advisors LLC acquired a new stake in shares of Centene in the first quarter valued at $25,000. WR Wealth Planners LLC lifted its holdings in Centene by 41.
4% in the 2nd quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock valued at $31,000 after acquiring an additional 137 shares during the last quarter. Chris Bulman Inc acquired a new position in shares of Centene in the 2nd quarter worth approximately $33,000.
Riverview Trust Co raised its holdings in shares of Centene by 154.6% in the 2nd quarter. Riverview Trust Co now owns 527 shares of the company’s stock worth $35,000 after purchasing an additional 320 shares in the last quarter.
Finally, Thurston Springer Miller Herd & Titak Inc. bought a new stake in Centene during the second quarter worth approximately $36,000. 93.
63% of the stock is owned by institutional investors and hedge funds. Centene Price Performance CNC opened at $75.35 on Monday.
The stock has a fifty day moving average price of $73.57 and a 200 day moving average price of $73.53.
The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.
64. Centene Co. has a 1 year low of $63.
45 and a 1 year high of $81.42. The stock has a market cap of $39.
64 billion, a price-to-earnings ratio of 14.98, a PEG ratio of 0.99 and a beta of 0.
48. Wall Street Analysts Forecast Growth Several research firms have issued reports on CNC. Deutsche Bank Aktiengesellschaft upped their price target on Centene from $82.
00 to $87.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Robert W.
Baird assumed coverage on Centene in a research report on Thursday, May 30th. They issued a “neutral” rating and a $83.00 price target for the company.
Wells Fargo & Company cut their price objective on Centene from $93.00 to $91.00 and set an “overweight” rating on the stock in a report on Friday.
Stephens reissued an “equal weight” rating and issued a $78.00 target price on shares of Centene in a research report on Monday, August 5th. Finally, Baird R W raised shares of Centene to a “hold” rating in a research note on Thursday, May 30th.
Seven analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $85.
58. Read Our Latest Research Report on CNC About Centene ( Free Report ) Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments.
The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support. Read More Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co.
( NYSE:CNC – Free Report ). Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter .
.
